John Simmerling

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

John Simmerling

Jan 12, 2025, 19:40 | Blog

John Simmerling: How cancer cells find ways to evade the human immune system

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared on LinkedIn:…

Jan 5, 2025, 14:12 | Blog

Strategies to reduce T-cell exhaustion in targeted immunotherapies

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

Jan 4, 2025, 16:32 | Insight

John Simmerling: Amazing molecular animation video on an activated T-cell engaging with a diseased cell

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

Dec 23, 2024, 15:38 | Insight

John Simmerling: An incredible microscopy of a ferocious, activated T-cell, killing a cancer cell

John Simmerling, Chief Science Officer at Biomedical and Healthcare Technology Solutions Group, shared a post…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023